After tough period for lobby, BIO chief Michelle McMurry-Heath goes on leave

WASHINGTON — Michelle McMurry-Heath, one of the most prominent faces of the drug industry in Washington, is on leave from her role as CEO of the Biotechnology Innovation Organization, the group confirmed on Sunday.

“The BIO CEO is currently on leave. BIO does not speculate on rumors relative to employees or personnel,” BIO Chief Public Affairs and Marketing Officer Rich Masters said.

It is unclear when the leave started. McMurry-Heath appeared in-person on behalf of BIO at a life sciences event in Philadelphia on Thursday. The Wall Street Journal first reported that McMurry-Heath was on leave.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In